ACRS
Aclaris Therapeutics Inc
3.70$
-13.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.94 | -0.72 | -1.09 | -1.62 | -1.95 | -3.06 | -2.33 | -0.91 | -0.92 | -1.04 | -1.12 | -0.26 | -0.38 | |
| 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | |
| – | 0.00 | 0.05 | 0.29 | 0.51 | 0.61 | 0.39 | 0.26 | 0.25 | 0.23 | 0.29 | 0.14 | 0.10 | |
| – | 0.00 | 0.06 | 0.43 | 0.45 | 0.65 | 1.53 | 0.32 | 0.69 | 0.30 | – | – | – | |
| 0.18 | 0.08 | -0.06 | 0.20 | 0.03 | 0.29 | -0.07 | -0.06 | -0.02 | -0.02 | 0.13 | 0.14 | 0.02 | |
| 0.00 | 0.04 | 0.03 | 0.01 | 0.04 | 0.04 | 0.04 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | |
| -2.71 | -0.17 | -4.13 | -2.89 | -1.98 | 0.28 | 2.56 | 0.15 | -2.95 | 0.19 | 0.66 | -0.90 | 0.39 | |
| – | – | 0.00 | 0.00 | 0.00 | – | – | 0.18 | 0.06 | – | – | – | – | |
| – | 5.94 | 5.18 | 5.46 | 3.57 | 3.06 | 0.01 | 0.18 | -0.06 | 0.00 | 0.00 | – | 0.00 | |
| – | -0.01 | 0.00 | 0.00 | 0.00 | 0.89 | -0.73 | 0.26 | -0.20 | 0.00 | 0.00 | – | – | |
| – | 0.99 | 5.18 | 5.46 | 3.57 | 3.90 | -0.73 | 0.43 | 3.97 | 1.12 | 0.38 | 0.96 | -0.05 | |
| -5.64 | 0.11 | -0.05 | 0.95 | -0.35 | 1.12 | -0.51 | -0.33 | 0.09 | 0.27 | -0.08 | -0.20 | -0.04 | |
| -2.94 | -0.76 | -1.12 | -1.63 | -1.99 | -3.10 | -2.37 | -0.92 | -0.92 | -1.05 | -1.14 | -0.26 | -0.38 |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.